Search

Your search keyword '"Fehm, Tanja N."' showing total 491 results
Start Over Author "Fehm, Tanja N."
491 results on '"Fehm, Tanja N."'

1. The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype

Author

Ziegler, Philipp, Hartkopf, Andreas D., Wallwiener, Markus, Häberle, Lothar, Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Ettl, Johannes, Lüftner, Diana, Müller, Volkmar, Michel, Laura L., Belleville, Erik, Wimberger, Pauline, Hielscher, Carsten, Huebner, Hanna, Uhrig, Sabrina, Wurmthaler, Lena A., Hack, Carolin C., Mundhenke, Christoph, Kurbacher, Christian, Fasching, Peter A., Wuerstlein, Rachel, Untch, Michael, Janni, Wolfgang, Taran, Florin-Andrei, Lux, Michael P., Wallwiener, Diethelm, Brucker, Sara Y., Fehm, Tanja N., Schneeweiss, Andreas, and Goossens, Chloë

Published
2024
Full Text
View/download PDF

2. Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

Author

Fasching, Peter A., Hu, Chunling, Hart, Steven N., Ruebner, Matthias, Polley, Eric C., Gnanaolivu, Rohan D., Hartkopf, Andreas D., Huebner, Hanna, Janni, Wolfgang, Hadji, Peyman, Tesch, Hans, Uhrig, Sabrina, Ettl, Johannes, Lux, Michael P., Lüftner, Diana, Wallwiener, Markus, Wurmthaler, Lena A., Goossens, Chloë, Müller, Volkmar, Beckmann, Matthias W., Hein, Alexander, Anetsberger, Daniel, Belleville, Erik, Wimberger, Pauline, Untch, Michael, Ekici, Arif B., Kolberg, Hans-Christian, Hartmann, Arndt, Taran, Florin-Andrei, Fehm, Tanja N., Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Häberle, Lothar, and Couch, Fergus J.

Published
2024
Full Text
View/download PDF

3. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

Author

Morra, Anna, Schreurs, Maartje AC, Andrulis, Irene L, Anton‐Culver, Hoda, Augustinsson, Annelie, Beckmann, Matthias W, Behrens, Sabine, Bojesen, Stig E, Bolla, Manjeet K, Brauch, Hiltrud, Broeks, Annegien, Buys, Saundra S, Camp, Nicola J, Castelao, Jose E, Cessna, Melissa H, Chang‐Claude, Jenny, Chung, Wendy K, Sahlberg, Kristine K, Børresen‐Dale, Anne‐Lise, Gram, Inger Torhild, Olsen, Karina Standahl, Engebråten, Olav, Naume, Bjørn, Geisler, Jürgen, OSBREAC, Alnæs, Grethe I Grenaker, Colonna, Sarah V, Couch, Fergus J, Cox, Angela, Cross, Simon S, Czene, Kamila, Daly, Mary B, Dennis, Joe, Devilee, Peter, Dörk, Thilo, Dunning, Alison M, Dwek, Miriam, Easton, Douglas F, Eccles, Diana M, Eriksson, Mikael, Evans, D Gareth, Fasching, Peter A, Fehm, Tanja N, Figueroa, Jonine D, Flyger, Henrik, Gabrielson, Marike, Gago‐Dominguez, Manuela, García‐Closas, Montserrat, García‐Sáenz, José A, Genkinger, Jeanine, Grassmann, Felix, Gündert, Melanie, Hahnen, Eric, Haiman, Christopher A, Hamann, Ute, Harrington, Patricia A, Hartikainen, Jaana M, Hoppe, Reiner, Hopper, John L, Houlston, Richard S, Howell, Anthony, Clarke, Christine, Marsh, Deborah, Scott, Rodney, Baxter, Robert, Yip, Desmond, Carpenter, Jane, Davis, Alison, Pathmanathan, Nirmala, Simpson, Peter, Graham, J Dinny, Sachchithananthan, Mythily, Amor, David, Andrews, Lesley, Antill, Yoland, Balleine, Rosemary, Beesley, Jonathan, Bennett, Ian, Bogwitz, Michael, Botes, Leon, Brennan, Meagan, Brown, Melissa, Buckley, Michael, Burke, Jo, Butow, Phyllis, Caldon, Liz, Campbell, Ian, Cao, Michelle, Chakrabarti, Anannya, Chauhan, Deepa, Chauhan, Manisha, Chenevix‐Trench, Georgia, Christian, Alice, Cohen, Paul, Colley, Alison, Crook, Ashley, Cui, James, Courtney, Eliza, Cummings, Margaret, and Dawson, Sarah‐Jane

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Women's Health, Breast Cancer, Clinical Research, Prevention, Cancer, Female, Humans, Breast Neoplasms, Checkpoint Kinase 2, Genetic Predisposition to Disease, Germ-Line Mutation, Heterozygote, Proportional Hazards Models, CHEK2 c.1100delC germline genetic variant, contralateral breast cancer risk, radiotherapy, survival, systemic treatment, NBCS Collaborators, ABCTB Investigators, kConFab Investigators, Biochemistry and Cell Biology, Oncology and carcinogenesis
Abstract

BackgroundBreast cancer (BC) patients with a germline CHEK2 c.1100delC variant have an increased risk of contralateral BC (CBC) and worse BC-specific survival (BCSS) compared to non-carriers.AimTo assessed the associations of CHEK2 c.1100delC, radiotherapy, and systemic treatment with CBC risk and BCSS.MethodsAnalyses were based on 82,701 women diagnosed with a first primary invasive BC including 963 CHEK2 c.1100delC carriers; median follow-up was 9.1 years. Differential associations with treatment by CHEK2 c.1100delC status were tested by including interaction terms in a multivariable Cox regression model. A multi-state model was used for further insight into the relation between CHEK2 c.1100delC status, treatment, CBC risk and death.ResultsThere was no evidence for differential associations of therapy with CBC risk by CHEK2 c.1100delC status. The strongest association with reduced CBC risk was observed for the combination of chemotherapy and endocrine therapy [HR (95% CI): 0.66 (0.55-0.78)]. No association was observed with radiotherapy. Results from the multi-state model showed shorter BCSS for CHEK2 c.1100delC carriers versus non-carriers also after accounting for CBC occurrence [HR (95% CI): 1.30 (1.09-1.56)].ConclusionSystemic therapy was associated with reduced CBC risk irrespective of CHEK2 c.1100delC status. Moreover, CHEK2 c.1100delC carriers had shorter BCSS, which appears not to be fully explained by their CBC risk.

Published
2023

6. Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole

Author

Fasching, Peter A., Hack, Carolin C., Nabieva, Naiba, Maass, Nicolai, Aktas, Bahriye, Kümmel, Sherko, Thomssen, Christoph, Wolf, Christopher, Kolberg, Hans-Christian, Brucker, Cosima, Janni, Wolfgang, Dall, Peter, Schneeweiss, Andreas, Marme, Frederik, Sütterlin, Marc W., Ruebner, Matthias, Theuser, Anna-Katharin, Kellner, Sara, Hofmann, Nadine M., Böhm, Sybille, Almstedt, Katrin, Lück, Hans-Joachim, Schmatloch, Sabine, Kalder, Matthias, Uleer, Christoph, Jurhasz-Böss, Ingolf, Hanf, Volker, Jackisch, Christian, Müller, Volkmar, Rack, Brigitte, Belleville, Erik, Wallwiener, Diethelm, Rody, Achim, Rauh, Claudia, Bayer, Christian M., Uhrig, Sabrina, Goossens, Chloë, Huebner, Hanna, Brucker, Sara Y., Hein, Alexander, Fehm, Tanja N., and Häberle, Lothar

Published
2024
Full Text
View/download PDF

7. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Author

Li, Shuai, Silvestri, Valentina, Leslie, Goska, Rebbeck, Timothy R, Neuhausen, Susan L, Hopper, John L, Nielsen, Henriette Roed, Lee, Andrew, Yang, Xin, McGuffog, Lesley, Parsons, Michael T, Andrulis, Irene L, Arnold, Norbert, Belotti, Muriel, Borg, Åke, Buecher, Bruno, Buys, Saundra S, Caputo, Sandrine M, Chung, Wendy K, Colas, Chrystelle, Colonna, Sarah V, Cook, Jackie, Daly, Mary B, de la Hoya, Miguel, de Pauw, Antoine, Delhomelle, Hélène, Eason, Jacqueline, Engel, Christoph, Evans, D Gareth, Faust, Ulrike, Fehm, Tanja N, Fostira, Florentia, Fountzilas, George, Frone, Megan, Garcia-Barberan, Vanesa, Garre, Pilar, Gauthier-Villars, Marion, Gehrig, Andrea, Glendon, Gord, Goldgar, David E, Golmard, Lisa, Greene, Mark H, Hahnen, Eric, Hamann, Ute, Hanson, Helen, Hassan, Tiara, Hentschel, Julia, Horvath, Judit, Izatt, Louise, Janavicius, Ramunas, Jiao, Yue, John, Esther M, Karlan, Beth Y, Kim, Sung-Won, Konstantopoulou, Irene, Kwong, Ava, Laugé, Anthony, Lee, Jong Won, Lesueur, Fabienne, Mebirouk, Noura, Meindl, Alfons, Mouret-Fourme, Emmanuelle, Musgrave, Hannah, Yie, Joanne Ngeow Yuen, Niederacher, Dieter, Park, Sue K, Pedersen, Inge Sokilde, Ramser, Juliane, Ramus, Susan J, Rantala, Johanna, Rashid, Muhammad U, Reichl, Florian, Ritter, Julia, Rump, Andreas, Santamariña, Marta, Saule, Claire, Schmidt, Gunnar, Schmutzler, Rita K, Senter, Leigha, Shariff, Saba, Singer, Christian F, Southey, Melissa C, Stoppa-Lyonnet, Dominique, Sutter, Christian, Tan, Yen, Teo, Soo Hwang, Terry, Mary Beth, Thomassen, Mads, Tischkowitz, Marc, Toland, Amanda E, Torres, Diana, Vega, Ana, Wagner, Sebastian A, Wang-Gohrke, Shan, Wappenschmidt, Barbara, Weber, Bernhard HF, Yannoukakos, Drakoulis, Spurdle, Amanda B, Easton, Douglas F, and Chenevix-Trench, Georgia

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Prostate Cancer, Women's Health, Digestive Diseases, Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Prevention, Cancer, Urologic Diseases, Rare Diseases, 2.1 Biological and endogenous factors, BRCA1 Protein, BRCA2 Protein, Breast Neoplasms, Breast Neoplasms, Male, Female, Genetic Predisposition to Disease, Heterozygote, Humans, Infant, Newborn, Male, Mutation, Ovarian Neoplasms, Pancreatic Neoplasms, Risk, Clinical Sciences, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

PurposeTo provide precise age-specific risk estimates of cancers other than female breast and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for effective cancer risk management.MethodsWe used data from 3,184 BRCA1 and 2,157 BRCA2 families in the Consortium of Investigators of Modifiers of BRCA1/2 to estimate age-specific relative (RR) and absolute risks for 22 first primary cancer types adjusting for family ascertainment.ResultsBRCA1 PVs were associated with risks of male breast (RR = 4.30; 95% CI, 1.09 to 16.96), pancreatic (RR = 2.36; 95% CI, 1.51 to 3.68), and stomach (RR = 2.17; 95% CI, 1.25 to 3.77) cancers. Associations with colorectal and gallbladder cancers were also suggested. BRCA2 PVs were associated with risks of male breast (RR = 44.0; 95% CI, 21.3 to 90.9), stomach (RR = 3.69; 95% CI, 2.40 to 5.67), pancreatic (RR = 3.34; 95% CI, 2.21 to 5.06), and prostate (RR = 2.22; 95% CI, 1.63 to 3.03) cancers. The stomach cancer RR was higher for females than males (6.89 v 2.76; P = .04). The absolute risks to age 80 years ranged from 0.4% for male breast cancer to approximately 2.5% for pancreatic cancer for BRCA1 carriers and from approximately 2.5% for pancreatic cancer to 27% for prostate cancer for BRCA2 carriers.ConclusionIn addition to female breast and ovarian cancers, BRCA1 and BRCA2 PVs are associated with increased risks of male breast, pancreatic, stomach, and prostate (only BRCA2 PVs) cancers, but not with the risks of other previously suggested cancers. The estimated age-specific risks will refine cancer risk management in men and women with BRCA1/2 PVs.

Published
2022

8. Return of individual genomic research results within the PRAEGNANT multicenter registry study

Author

Huebner, Hanna, Ruebner, Matthias, Kurbacher, Christian, Hadji, Peyman, Hartkopf, Andreas D., Lux, Michael P., Huober, Jens, Uhrig, Sabrina, Taran, Florin-Andrei, Overkamp, Friedrich, Tesch, Hans, Häberle, Lothar, Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Beckmann, Matthias W., Hein, Alexander, Belleville, Erik, Untch, Michael, Janni, Wolfgang, Fehm, Tanja N., Kolberg, Hans-Christian, Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Ettl, Johannes, Fasching, Peter A., and Michel, Laura L.

Published
2023
Full Text
View/download PDF

9. Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

Author

Fasching, Peter A., Hein, Alexander, Kolberg, Hans-Christian, Häberle, Lothar, Uhrig, Sabrina, Rübner, Matthias, Belleville, Erik, Hack, Carolin C., Fehm, Tanja N., Janni, Wolfang, Hartmann, Arndt, Erber, Ramona, Theuser, Anna-Katharin, Brucker, Sara Y., Hartkopf, Andreas D., and Untch, Michael

Published
2023
Full Text
View/download PDF

10. The SURVIVE study: Liquid biopsy guided surveillance after intermediate- to high-risk early breast cancer.

Author

Pfister, Kerstin, primary, Huesmann, Sophia, additional, Friedl, Thomas W. P., additional, Fink, Angelina, additional, Mehmeti, Forca, additional, Mergel, Franziska, additional, Schäffler, Henning, additional, Heublein, Sabine, additional, Hartkopf, Andreas Daniel, additional, Mueller, Volkmar, additional, Wiesmueller, Lisa Maria, additional, Fehm, Tanja N., additional, Pantel, Klaus, additional, Rack, Brigitte, additional, and Janni, Wolfgang, additional

Published
2024
Full Text
View/download PDF

12. Retrospective Impact of COVID-19 Pandemic on Primary Breast Cancer Care.

Author

Pruss, Maximilian, Neubacher, Melissa, Dietzel, Frederic, Krawczyk, Natalia, Cieslik, Jan-Philipp, Mohrmann, Svjetlana, Ruckhäberle, Eugen, Sturm-Inwald, Elisabeth C., Fehm, Tanja N., and Behrens, Bianca

Subjects
TUMOR treatment, TUMOR diagnosis, BREAST tumors, CANCER patient medical care, EARLY detection of cancer, MEDICAL care, CANCER patients, PSYCHOLOGICAL adaptation, SOCIAL support, TUMOR classification, COVID-19 pandemic
Abstract

Background: The COVID-19 pandemic has transformed breast cancer care for patients and healthcare providers. Circumstances varied greatly by region and hospital, depending on COVID-19 prevalence, case mix, hospital type, and available resources. These challenges have disrupted screening programs and have been particularly distressing for both women with a breast cancer diagnosis and their providers. Summary: This review explores the retrospective impact of the COVID-19 pandemic on primary breast cancer care. It analyzes changes in screening participation, diagnosis rates, treatment modalities, and the delivery of psycho-oncological support during the pandemic. The study found a significant reduction in breast cancer screenings and a subsequent stage shift in diagnoses, with fewer early-stage and more advanced-stage cancers being detected. Additionally, the review discusses the psychosocial challenges faced by patients and the adaptations made in care delivery, such as the increased use of telemedicine. Despite these challenges, the healthcare systems showed resilience, with core treatment services largely maintained and rapid adaptations to new care models. Key Messages: There was a marked decrease in breast cancer screenings and early diagnoses during the pandemic, with a shift toward more advanced-stage detections. While there was an increased use of neoadjuvant therapies and telemedicine, essential breast cancer treatments were mostly sustained, reflecting the resilience of healthcare systems. The pandemic significantly impacted the mental health of breast cancer patients, exacerbating anxiety and depression and highlighting the need for improved psycho-oncological support. The full impact of these disruptions on long-term breast cancer outcomes remains uncertain, necessitating ongoing monitoring and adaptation of care strategies to mitigate adverse effects. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. Predictive Clinical Decision Support System with RNN Encoding and Tensor Decoding

Author

Yang, Yinchong, Fasching, Peter A., Wallwiener, Markus, Fehm, Tanja N., Brucker, Sara Y., and Tresp, Volker

Subjects
Computer Science - Learning
Abstract

With the introduction of the Electric Health Records, large amounts of digital data become available for analysis and decision support. When physicians are prescribing treatments to a patient, they need to consider a large range of data variety and volume, making decisions increasingly complex. Machine learning based Clinical Decision Support systems can be a solution to the data challenges. In this work we focus on a class of decision support in which the physicians' decision is directly predicted. Concretely, the model would assign higher probabilities to decisions that it presumes the physician are more likely to make. Thus the CDS system can provide physicians with rational recommendations. We also address the problem of correlation in target features: Often a physician is required to make multiple (sub-)decisions in a block, and that these decisions are mutually dependent. We propose a solution to the target correlation problem using a tensor factorization model. In order to handle the patients' historical information as sequential data, we apply the so-called Encoder-Decoder-Framework which is based on Recurrent Neural Networks (RNN) as encoders and a tensor factorization model as a decoder, a combination which is novel in machine learning. With experiments with real-world datasets we show that the proposed model does achieve better prediction performances.

Published
2016

14. Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer

Author

Würstlein, Rachel, additional, Kolberg, Hans-Christian, additional, Hartkopf, Andreas D., additional, Fehm, Tanja N., additional, Welslau, Manfred, additional, Schütz, Florian, additional, Fasching, Peter A., additional, Janni, Wolfgang, additional, Witzel, Isabell, additional, Thomssen, Christoph, additional, Krückel, Annika, additional, Belleville, Erik, additional, Lüftner, Diana, additional, Untch, Michael, additional, Thill, Marc, additional, Hörner, Manuel, additional, Tesch, Hans, additional, Ditsch, Nina, additional, Lux, Michael P., additional, Aktas, Bahriye, additional, Banys-Paluchowski, Maggie, additional, Taran, Florin-Andrei, additional, Wöckel, Achim, additional, Harbeck, Nadia, additional, Stickeler, Elmar, additional, Bartsch, Rupert, additional, Schneeweiss, Andreas, additional, Ettl, Johannes, additional, Krug, David, additional, and Müller, Volkmar, additional

Published
2024
Full Text
View/download PDF

16. Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study

Author

Hein, Alexander, primary, Fasching, Peter A., primary, Hack, Carolin C., additional, Maass, Nicolai, additional, Aktas, Bahriye, additional, Kümmel, Sherko, additional, Thomssen, Christoph, additional, Wolf, Christopher, additional, Kolberg, Hans-Christian, additional, Brucker, Cosima, additional, Janni, Wolfgang, additional, Dall, Peter, additional, Schneeweiss, Andreas, additional, Marme, Frederik, additional, Ruebner, Matthias, additional, Theuser, Anna-Katharin, additional, Hofmann, Nadine M., additional, Böhm, Sybille, additional, Almstedt, Katrin, additional, Kellner, Sara, additional, Nabieva, Naiba, additional, Gass, Paul, additional, Sütterlin, Marc W., additional, Lück, Hans-Joachim, additional, Schmatloch, Sabine, additional, Kalder, Matthias, additional, Uleer, Christoph, additional, Juhasz-Böss, Ingolf, additional, Hanf, Volker, additional, Jackisch, Christian, additional, Müller, Volkmar, additional, Rack, Brigitte, additional, Belleville, Erik, additional, Wallwiener, Diethelm, additional, Rody, Achim, additional, Rauh, Claudia, additional, Bayer, Christian M., additional, Uhrig, Sabrina, additional, Goossens, Chloë, additional, Huebner, Hanna, additional, Brucker, Sara Y., additional, Häberle, Lothar, additional, and Fehm, Tanja N., additional

Published
2024
Full Text
View/download PDF

17. CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs

Author

Schneeweiss, Andreas, additional, Brucker, Sara Y., additional, Huebner, Hanna, additional, Volmer, Lea L., additional, Hack, Carolin C., additional, Seitz, Katharina, additional, Ruebner, Matthias, additional, Heublein, Sabine, additional, Thewes, Verena, additional, Lüftner, Diana, additional, Lux, Michael P., additional, Jurhasz-Böss, Ingolf, additional, Taran, Florin-Andrei, additional, Wimberger, Pauline, additional, Anetsberger, Daniel, additional, Beierlein, Milena, additional, Schmidt, Marcus, additional, Radosa, Julia, additional, Müller, Volkmar, additional, Janni, Wolfgang, additional, Rack, Brigitte, additional, Belleville, Erik, additional, Untch, Michael, additional, Thill, Marc, additional, Ditsch, Nina, additional, Aktas, Bahriye, additional, Nel, Ivonne, additional, Kolberg, Hans-Christian, additional, Engerle, Tobias, additional, Tesch, Hans, additional, Roos, Christian, additional, Budden, Christina, additional, Neubauer, Hans, additional, Hartkopf, Andreas D., additional, Fehm, Tanja N., additional, and Fasching, Peter A., additional

Published
2024
Full Text
View/download PDF

18. Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry

Author

Hartkopf, Andreas D., primary, Walter, Christina B., primary, Kolberg, Hans-Christian, additional, Hadji, Peyman, additional, Tesch, Hans, additional, Fasching, Peter A., additional, Ettl, Johannes, additional, Lüftner, Diana, additional, Wallwiener, Markus, additional, Müller, Volkmar, additional, Beckmann, Matthias W., additional, Belleville, Erik, additional, Huebner, Hanna, additional, Uhrig, Sabrina, additional, Goossens, Chloë, additional, Link, Theresa, additional, Hielscher, Carsten, additional, Mundhenke, Christoph, additional, Kurbacher, Christian, additional, Wuerstlein, Rachel, additional, Untch, Michael, additional, Janni, Wolfgang, additional, Taran, Florin-Andrei, additional, Michel, Laura L., additional, Lux, Michael P., additional, Wallwiener, Diethelm, additional, Brucker, Sara Y., additional, Fehm, Tanja N., additional, Häberle, Lothar, additional, and Schneeweiss, Andreas, additional

Published
2024
Full Text
View/download PDF

19. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

Author

Schneeweiss, Andreas, Ettl, Johannes, Lüftner, Diana, Beckmann, Matthias W., Belleville, Erik, Fasching, Peter A., Fehm, Tanja N., Geberth, Matthias, Häberle, Lothar, Hadji, Peyman, Hartkopf, Andreas D., Hielscher, Carsten, Huober, Jens, Ruckhäberle, Eugen, Janni, Wolfgang, Kolberg, Hans Christian, Kurbacher, Christian M., Klein, Evelyn, Lux, Michael P., Müller, Volkmar, Nabieva, Naiba, Overkamp, Friedrich, Tesch, Hans, Laakmann, Elena, Taran, Florin-Andrei, Seitz, Julia, Thomssen, Christoph, Untch, Michael, Wimberger, Pauline, Wuerstlein, Rachel, Volz, Bernhard, Wallwiener, Diethelm, Wallwiener, Markus, and Brucker, Sara Y.

Published
2020
Full Text
View/download PDF

21. Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study

Author

Hein, Alexander, primary, Fasching, Peter A., primary, Hack, Carolin C., additional, Maass, Nicolai, additional, Aktas, Bahriye, additional, Kümmel, Sherko, additional, Thomssen, Christoph, additional, Wolf, Christopher, additional, Kolberg, Hans-Christian, additional, Brucker, Cosima, additional, Janni, Wolfgang, additional, Dall, Peter, additional, Schneeweiss, Andreas, additional, Marme, Frederik, additional, Ruebner, Matthias, additional, Theuser, Anna-Katharin, additional, Hofmann, Nadine M., additional, Böhm, Sybille, additional, Almstedt, Katrin, additional, Kellner, Sara, additional, Nabieva, Naiba, additional, Gass, Paul, additional, Sütterlin, Marc W., additional, Lück, Hans-Joachim, additional, Schmatloch, Sabine, additional, Kalder, Matthias, additional, Uleer, Christoph, additional, Juhasz-Böss, Ingolf, additional, Hanf, Volker, additional, Jackisch, Christian, additional, Müller, Volkmar, additional, Rack, Brigitte, additional, Belleville, Erik, additional, Wallwiener, Diethelm, additional, Rody, Achim, additional, Rauh, Claudia, additional, Bayer, Christian M., additional, Uhrig, Sabrina, additional, Goossens, Chloë, additional, Huebner, Hanna, additional, Brucker, Sara Y., additional, Häberle, Lothar, additional, and Fehm, Tanja N., additional

Published
2024
Full Text
View/download PDF

22. Update Mammakarzinom 2023 Teil 2 – Brustkrebs in fortgeschrittenen Krankheitsstadien

Author

Lux, Michael P., additional, Hartkopf, Andreas D., additional, Fehm, Tanja N., additional, Welslau, Manfred, additional, Müller, Volkmar, additional, Schütz, Florian, additional, Fasching, Peter A., additional, Janni, Wolfgang, additional, Witzel, Isabell, additional, Thomssen, Christoph, additional, Beierlein, Milena, additional, Belleville, Erik, additional, Untch, Michael, additional, Thill, Marc, additional, Tesch, Hans, additional, Ditsch, Nina, additional, Aktas, Bahriye, additional, Banys-Paluchowski, Maggie, additional, Kolberg-Liedtke, Cornelia, additional, Wöckel, Achim, additional, Kolberg, Hans-Christian, additional, Harbeck, Nadia, additional, Bartsch, Rupert, additional, Schneeweiss, Andreas, additional, Ettl, Johannes, additional, Würstlein, Rachel, additional, Krug, David, additional, Taran, Florin-Andrei, additional, Lüftner, Diana, additional, and Stickeler, Elmar, additional

Published
2023
Full Text
View/download PDF

23. Update Mammakarzinom 2023 Teil 3 – Expertenmeinungen zu Brustkrebs in frühen Krankheitsstadien

Author

Kolberg, Hans-Christian, additional, Hartkopf, Andreas D., additional, Fehm, Tanja N., additional, Welslau, Manfred, additional, Müller, Volkmar, additional, Schütz, Florian, additional, Fasching, Peter A., additional, Janni, Wolfgang, additional, Witzel, Isabell, additional, Thomssen, Christoph, additional, Beierlein, Milena, additional, Belleville, Erik, additional, Untch, Michael, additional, Thill, Marc, additional, Tesch, Hans, additional, Ditsch, Nina, additional, Lux, Michael P., additional, Aktas, Bahriye, additional, Banys-Paluchowski, Maggie, additional, Kolberg-Liedtke, Cornelia, additional, Wöckel, Achim, additional, Harbeck, Nadia, additional, Stickeler, Elmar, additional, Bartsch, Rupert, additional, Schneeweiss, Andreas, additional, Ettl, Johannes, additional, Krug, David, additional, Taran, Florin-Andrei, additional, Lüftner, Diana, additional, and Würstlein, Rachel, additional

Published
2023
Full Text
View/download PDF

26. Klinische Endpunkte in Real-World-Register-Studien: PRAEGNANT-Netzwerk für Patientinnen mit fortgeschrittenem Mammakarzinom

Author

Hartkopf, Andreas D., Emons, Julius, Lux, Michael P., Taran, Florin-Andrei, Overkamp, Friedrich, Tesch, Hans, Titzmann, Adriana, Pöschke, Patrik, Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Beckmann, Matthias W., Belleville, Erik, Janni, Wolfgang, Fehm, Tanja N., Kolberg, Hans-Christian, Ettl, Johannes, Wallwiener, Diethelm, Schneeweiss, Andreas, Brucker, Sara Y., and Fasching, Peter A.

Published
2020
Full Text
View/download PDF

27. Systemische Therapie von prämenopausalen Patientinnen mit hormonrezeptorpositivem, HER2-negativem Brustkrebs in den Frühstadien – Kontroversen und Standards in der Krankenversorgung.

Author

Müller, Volkmar, Fasching, Peter A., Nabieva, Naiba, Fehm, Tanja N., Thill, Marc, Schmidt, Marcus, Kühn, Thorsten, Banys-Paluchowski, Maggie, Belleville, Erik, Juhasz-Böss, Ingolf, Untch, Michael, Kolberg, Hans-Christian, Harbeck, Nadia, Aktas, Bahriye, Stickeler, Elmar, Kreuzeder, Julia, Hartkopf, Andreas D., Janni, Wolfgang, and Ditsch, Nina

Published
2024
Full Text
View/download PDF

28. Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies

Author

Kolberg, Hans-Christian, additional, Hartkopf, Andreas D., additional, Fehm, Tanja N., additional, Welslau, Manfred, additional, Müller, Volkmar, additional, Schütz, Florian, additional, Fasching, Peter A., additional, Janni, Wolfgang, additional, Witzel, Isabell, additional, Thomssen, Christoph, additional, Beierlein, Milena, additional, Belleville, Erik, additional, Untch, Michael, additional, Thill, Marc, additional, Tesch, Hans, additional, Ditsch, Nina, additional, Lux, Michael P., additional, Aktas, Bahriye, additional, Banys-Paluchowski, Maggie, additional, Kolberg-Liedtke, Cornelia, additional, Wöckel, Achim, additional, Harbeck, Nadia, additional, Stickeler, Elmar, additional, Bartsch, Rupert, additional, Schneeweiss, Andreas, additional, Ettl, Johannes, additional, Krug, David, additional, Taran, Florin-Andrei, additional, Lüftner, Diana, additional, and Würstlein, Rachel, additional

Published
2023
Full Text
View/download PDF

30. Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

Author

Hartkopf, Andreas D., Huober, Jens, Volz, Bernhard, Nabieva, Naiba, Taran, Florin-Andrei, Schwitulla, Judith, Overkamp, Friedrich, Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Häberle, Lothar, Ettl, Johannes, Lux, Michael P., Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Beckmann, Matthias W., Belleville, Erik, Wimberger, Pauline, Hielscher, Carsten, Geberth, Matthias, Fersis, Nikos, Abenhardt, Wolfgang, Kurbacher, Christian, Wuerstlein, Rachel, Thomssen, Christoph, Untch, Michael, Fasching, Peter A., Janni, Wolfgang, Fehm, Tanja N., Wallwiener, Diethelm, Brucker, Sara Y., and Schneeweiss, Andreas

Published
2018
Full Text
View/download PDF

31. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

Author

Müller, Volkmar, Nabieva, Naiba, Häberle, Lothar, Taran, Florin-Andrei, Hartkopf, Andreas D., Volz, Bernhard, Overkamp, Friedrich, Brandl, Anna Lisa, Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Ettl, Johannes, Lux, Michael P., Lüftner, Diana, Belleville, Erik, Fasching, Peter A., Janni, Wolfgang, Beckmann, Matthias W., Wimberger, Pauline, Hielscher, Carsten, Fehm, Tanja N., Brucker, Sara Y., Wallwiener, Diethelm, Schneeweiss, Andreas, and Wallwiener, Markus

Published
2018
Full Text
View/download PDF

32. Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

Author

Fasching, Peter A., Hartkopf, Andreas D., Gass, Paul, Häberle, Lothar, Akpolat-Basci, Leyla, Hein, Alexander, Volz, Bernhard, Taran, Florin-Andrei, Nabieva, Naiba, Pott, Birgit, Overkamp, Friedrich, Einarson, Hanna, Hadji, Peyman, Tesch, Hans, Ettl, Johannes, Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Janni, Wolfgang, Fehm, Tanja N., Schneeweiss, Andreas, Untch, Michael, Pott, Dirk, Lux, Michael P., Geyer, Thomas, Liedtke, Cornelia, Seeger, Harald, Wetzig, Sarah, Hartmann, Arndt, Schulz-Wendtland, Rüdiger, Belleville, Erik, Wallwiener, Diethelm, Beckmann, Matthias W., Brucker, Sara Y., and Kolberg, Hans-Christian

Published
2019
Full Text
View/download PDF

33. Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

Author

Huebner, Hanna, Kurbacher, Christian M., Kuesters, Geoffrey, Hartkopf, Andreas D., Lux, Michael P., Huober, Jens, Volz, Bernhard, Taran, Florin-Andrei, Overkamp, Friedrich, Tesch, Hans, Häberle, Lothar, Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Beckmann, Matthias W., Belleville, Erik, Ruebner, Matthias, Untch, Michael, Fasching, Peter A., Janni, Wolfgang, Fehm, Tanja N., Kolberg, Hans-Christian, Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, and Ettl, Johannes

Published
2020
Full Text
View/download PDF

34. Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer

Author

Hartkopf, Andreas D., additional, Fehm, Tanja N., additional, Welslau, Manfred, additional, Müller, Volkmar, additional, Schütz, Florian, additional, Fasching, Peter A., additional, Janni, Wolfgang, additional, Witzel, Isabell, additional, Thomssen, Christoph, additional, Beierlein, Milena, additional, Belleville, Erik, additional, Untch, Michael, additional, Thill, Marc, additional, Tesch, Hans, additional, Ditsch, Nina, additional, Lux, Michael P., additional, Aktas, Bahriye, additional, Banys-Paluchowski, Maggie, additional, Kolberg-Liedtke, Cornelia, additional, Wöckel, Achim, additional, Kolberg, Hans-Christian, additional, Harbeck, Nadia, additional, Stickeler, Elmar, additional, Bartsch, Rupert, additional, Schneeweiss, Andreas, additional, Ettl, Johannes, additional, Würstlein, Rachel, additional, Krug, David, additional, Taran, Florin-Andrei, additional, and Lüftner, Diana, additional

Published
2023
Full Text
View/download PDF

35. Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer

Author

Lux, Michael P., additional, Hartkopf, Andreas D., additional, Fehm, Tanja N., additional, Welslau, Manfred, additional, Müller, Volkmar, additional, Schütz, Florian, additional, Fasching, Peter A., additional, Janni, Wolfgang, additional, Witzel, Isabell, additional, Thomssen, Christoph, additional, Beierlein, Milena, additional, Belleville, Erik, additional, Untch, Michael, additional, Thill, Marc, additional, Tesch, Hans, additional, Ditsch, Nina, additional, Aktas, Bahriye, additional, Banys-Paluchowski, Maggie, additional, Kolberg-Liedtke, Cornelia, additional, Wöckel, Achim, additional, Kolberg, Hans-Christian, additional, Harbeck, Nadia, additional, Bartsch, Rupert, additional, Schneeweiss, Andreas, additional, Ettl, Johannes, additional, Würstlein, Rachel, additional, Krug, David, additional, Taran, Florin-Andrei, additional, Lüftner, Diana, additional, and Stickeler, Elmar, additional

Published
2023
Full Text
View/download PDF

36. Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer

Author

Schramm, Amelie, Schochter, Fabienne, Friedl, Thomas W.P., de Gregorio, Nikolaus, Andergassen, Ulrich, Alunni-Fabbroni, Marianna, Trapp, Elisabeth, Jaeger, Bernadette, Heinrich, Georg, Camara, Oumar, Decker, Thomas, Ober, Angelika, Mahner, Sven, Fehm, Tanja N., Pantel, Klaus, Fasching, Peter A., Schneeweiss, Andreas, Janni, Wolfgang, and Rack, Brigitte K.

Published
2017
Full Text
View/download PDF

37. Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial

Author

de Gregorio, Amelie, Häberle, Lothar, Fasching, Peter A., Müller, Volkmar, Schrader, Iris, Lorenz, Ralf, Forstbauer, Helmut, Friedl, Thomas W. P., Bauer, Emanuel, de Gregorio, Nikolaus, Deniz, Miriam, Fink, Visnja, Bekes, Inga, Andergassen, Ulrich, Schneeweiss, Andreas, Tesch, Hans, Mahner, Sven, Brucker, Sara Y., Blohmer, Jens-Uwe, Fehm, Tanja N., Heinrich, Georg, Lato, Krisztian, Beckmann, Matthias W., Rack, Brigitte, and Janni, Wolfgang

Published
2020
Full Text
View/download PDF

38. PGRMC1 effects on metabolism, genomic mutation and CpG methylation imply crucial roles in animal biology and disease

Author

Thejer, Bashar M., Adhikary, Partho P., Teakel, Sarah L., Fang, Johnny, Weston, Paul A., Gurusinghe, Saliya, Anwer, Ayad G., Gosnell, Martin, Jazayeri, Jalal A., Ludescher, Marina, Gray, Lesley-Ann, Pawlak, Michael, Wallace, Robyn H., Pant, Sameer D., Wong, Marie, Fischer, Tamas, New, Elizabeth J., Fehm, Tanja N., Neubauer, Hans, Goldys, Ewa M., Quinn, Jane C., Weston, Leslie A., and Cahill, Michael A.

Published
2020
Full Text
View/download PDF

39. PGRMC1 phosphorylation affects cell shape, motility, glycolysis, mitochondrial form and function, and tumor growth

Author

Thejer, Bashar M., Adhikary, Partho P., Kaur, Amandeep, Teakel, Sarah L., Van Oosterum, Ashleigh, Seth, Ishith, Pajic, Marina, Hannan, Katherine M., Pavy, Megan, Poh, Perlita, Jazayeri, Jalal A., Zaw, Thiri, Pascovici, Dana, Ludescher, Marina, Pawlak, Michael, Cassano, Juan C., Turnbull, Lynne, Jazayeri, Mitra, James, Alexander C., Coorey, Craig P., Roberts, Tara L., Kinder, Simon J., Hannan, Ross D., Patrick, Ellis, Molloy, Mark P., New, Elizabeth J., Fehm, Tanja N., Neubauer, Hans, Goldys, Ewa M., Weston, Leslie A., and Cahill, Michael A.

Published
2020
Full Text
View/download PDF

41. Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare

Author

Müller, Volkmar, additional, Fasching, Peter A., additional, Nabieva, Naiba, additional, Fehm, Tanja N., additional, Thill, Marc, additional, Schmidt, Marcus, additional, Kühn, Thorsten, additional, Banys-Paluchowski, Maggie, additional, Belleville, Erik, additional, Juhasz-Böss, Ingolf, additional, Untch, Michael, additional, Kolberg, Hans-Christian, additional, Harbeck, Nadia, additional, Aktas, Bahriye, additional, Stickeler, Elmar, additional, Kreuzeder, Julia, additional, Hartkopf, Andreas D., additional, Janni, Wolfgang, additional, and Ditsch, Nina, additional

Published
2023
Full Text
View/download PDF

42. Supplementary figure 2-3 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma

Author

Wang, Hui, primary, Schaefer, Thorsten, primary, Konantz, Martina, primary, Braun, Martin, primary, Varga, Zsuzsanna, primary, Paczulla, Anna M., primary, Reich, Selina, primary, Jacob, Francis, primary, Perner, Sven, primary, Moch, Holger, primary, Fehm, Tanja N., primary, Kanz, Lothar, primary, Schulze-Osthoff, Klaus, primary, and Lengerke, Claudia, primary

Published
2023
Full Text
View/download PDF

43. Supplementary figure 5 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma

Author

Wang, Hui, primary, Schaefer, Thorsten, primary, Konantz, Martina, primary, Braun, Martin, primary, Varga, Zsuzsanna, primary, Paczulla, Anna M., primary, Reich, Selina, primary, Jacob, Francis, primary, Perner, Sven, primary, Moch, Holger, primary, Fehm, Tanja N., primary, Kanz, Lothar, primary, Schulze-Osthoff, Klaus, primary, and Lengerke, Claudia, primary

Published
2023
Full Text
View/download PDF

44. Supplementary figure 7-8 and Table 2 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma

Author

Wang, Hui, primary, Schaefer, Thorsten, primary, Konantz, Martina, primary, Braun, Martin, primary, Varga, Zsuzsanna, primary, Paczulla, Anna M., primary, Reich, Selina, primary, Jacob, Francis, primary, Perner, Sven, primary, Moch, Holger, primary, Fehm, Tanja N., primary, Kanz, Lothar, primary, Schulze-Osthoff, Klaus, primary, and Lengerke, Claudia, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure from Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

Author

Fasching, Peter A., primary, Liu, Duan, primary, Scully, Steve, primary, Ingle, James N., primary, Lyra, Paulo C., primary, Rack, Brigitte, primary, Hein, Alexander, primary, Ekici, Arif B., primary, Reis, Andre, primary, Schneeweiss, Andreas, primary, Tesch, Hans, primary, Fehm, Tanja N., primary, Heinrich, Georg, primary, Beckmann, Matthias W., primary, Ruebner, Matthias, primary, Huebner, Hanna, primary, Lambrechts, Diether, primary, Madden, Ebony, primary, Shen, Jess, primary, Romm, Jane, primary, Doheny, Kim, primary, Jenkins, Gregory D., primary, Carlson, Erin E., primary, Li, Liang, primary, Fridley, Brooke L., primary, Cunningham, Julie M., primary, Janni, Wolfgang, primary, Monteiro, Alvaro N.A., primary, Schaid, Daniel J., primary, Häberle, Lothar, primary, Weinshilboum, Richard M., primary, and Wang, Liewei, primary

Published
2023
Full Text
View/download PDF

46. Data from Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

Author

Fasching, Peter A., primary, Liu, Duan, primary, Scully, Steve, primary, Ingle, James N., primary, Lyra, Paulo C., primary, Rack, Brigitte, primary, Hein, Alexander, primary, Ekici, Arif B., primary, Reis, Andre, primary, Schneeweiss, Andreas, primary, Tesch, Hans, primary, Fehm, Tanja N., primary, Heinrich, Georg, primary, Beckmann, Matthias W., primary, Ruebner, Matthias, primary, Huebner, Hanna, primary, Lambrechts, Diether, primary, Madden, Ebony, primary, Shen, Jess, primary, Romm, Jane, primary, Doheny, Kim, primary, Jenkins, Gregory D., primary, Carlson, Erin E., primary, Li, Liang, primary, Fridley, Brooke L., primary, Cunningham, Julie M., primary, Janni, Wolfgang, primary, Monteiro, Alvaro N.A., primary, Schaid, Daniel J., primary, Häberle, Lothar, primary, Weinshilboum, Richard M., primary, and Wang, Liewei, primary

Published
2023
Full Text
View/download PDF

47. Data from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma

Author

Wang, Hui, primary, Schaefer, Thorsten, primary, Konantz, Martina, primary, Braun, Martin, primary, Varga, Zsuzsanna, primary, Paczulla, Anna M., primary, Reich, Selina, primary, Jacob, Francis, primary, Perner, Sven, primary, Moch, Holger, primary, Fehm, Tanja N., primary, Kanz, Lothar, primary, Schulze-Osthoff, Klaus, primary, and Lengerke, Claudia, primary

Published
2023
Full Text
View/download PDF

48. Supplementary figure 6 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma

Author

Wang, Hui, primary, Schaefer, Thorsten, primary, Konantz, Martina, primary, Braun, Martin, primary, Varga, Zsuzsanna, primary, Paczulla, Anna M., primary, Reich, Selina, primary, Jacob, Francis, primary, Perner, Sven, primary, Moch, Holger, primary, Fehm, Tanja N., primary, Kanz, Lothar, primary, Schulze-Osthoff, Klaus, primary, and Lengerke, Claudia, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Data from Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

Author

Fasching, Peter A., primary, Liu, Duan, primary, Scully, Steve, primary, Ingle, James N., primary, Lyra, Paulo C., primary, Rack, Brigitte, primary, Hein, Alexander, primary, Ekici, Arif B., primary, Reis, Andre, primary, Schneeweiss, Andreas, primary, Tesch, Hans, primary, Fehm, Tanja N., primary, Heinrich, Georg, primary, Beckmann, Matthias W., primary, Ruebner, Matthias, primary, Huebner, Hanna, primary, Lambrechts, Diether, primary, Madden, Ebony, primary, Shen, Jess, primary, Romm, Jane, primary, Doheny, Kim, primary, Jenkins, Gregory D., primary, Carlson, Erin E., primary, Li, Liang, primary, Fridley, Brooke L., primary, Cunningham, Julie M., primary, Janni, Wolfgang, primary, Monteiro, Alvaro N.A., primary, Schaid, Daniel J., primary, Häberle, Lothar, primary, Weinshilboum, Richard M., primary, and Wang, Liewei, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure 1 and Table 1 from Prominent Oncogenic Roles of EVI1 in Breast Carcinoma

Author

Wang, Hui, primary, Schaefer, Thorsten, primary, Konantz, Martina, primary, Braun, Martin, primary, Varga, Zsuzsanna, primary, Paczulla, Anna M., primary, Reich, Selina, primary, Jacob, Francis, primary, Perner, Sven, primary, Moch, Holger, primary, Fehm, Tanja N., primary, Kanz, Lothar, primary, Schulze-Osthoff, Klaus, primary, and Lengerke, Claudia, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results